TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
10,611
|
10,456
|
9,024 |
Financial expenses |
42
|
24
|
41 |
Earnings before taxes |
1,867
|
1,474
|
1,223 |
EBITDA |
2,338
|
2,047
|
1,901 |
Total assets |
10,955
|
10,249
|
10,839 |
Current assets |
3,269
|
2,509
|
3,169 |
Current liabilities |
2,512
|
2,665
|
2,086 |
Equity capital |
8,369
|
7,509
|
6,658 |
- share capital |
2,389
|
2,599
|
2,648 |
Employees (average) |
21
|
23
|
19 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
76.4%
|
73.3%
|
61.4% |
Turnover per employee |
505
|
455
|
475 |
Profit as a percentage of turnover |
17.6%
|
14.1%
|
13.6% |
Return on assets (ROA) |
17.4%
|
14.6%
|
11.7% |
Current ratio |
130.1%
|
94.1%
|
151.9% |
Return on equity (ROE) |
22.3%
|
19.6%
|
18.4% |
Change turnover |
1,002
|
1,599
|
-2,292 |
Change turnover % |
10%
|
18%
|
-20% |
Chg. No. of employees |
-2
|
4
|
-1 |
Chg. No. of employees % |
-9%
|
21%
|
-5% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.